1. Home
  2. LGN vs AAPG Comparison

LGN vs AAPG Comparison

Compare LGN & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LGN

Legence Corp.

N/A

Current Price

$48.45

Market Cap

2.4B

Sector

N/A

ML Signal

N/A

Logo Ascentage Pharma Group International American Depository Shares

AAPG

Ascentage Pharma Group International American Depository Shares

N/A

Current Price

$26.01

Market Cap

2.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LGN
AAPG
Founded
1963
2009
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.6B
IPO Year
2025
2025

Fundamental Metrics

Financial Performance
Metric
LGN
AAPG
Price
$48.45
$26.01
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
5
Target Price
$43.43
$48.50
AVG Volume (30 Days)
1.1M
4.1K
Earning Date
11-14-2025
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,361,064,000.00
$54,524,554.00
Revenue This Year
$17.08
N/A
Revenue Next Year
$32.52
$368.64
P/E Ratio
N/A
N/A
Revenue Growth
46.19
N/A
52 Week Low
$26.96
$16.50
52 Week High
$50.20
$48.45

Technical Indicators

Market Signals
Indicator
LGN
AAPG
Relative Strength Index (RSI) N/A 37.96
Support Level N/A $27.48
Resistance Level N/A $28.49
Average True Range (ATR) 0.00 0.52
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
LGN
AAPG

About LGN Legence Corp.

Legence Corp is a provider of engineering, installation and maintenance services for mission-critical systems in buildings. It focuses on high-growth sectors that have technically demanding buildings, including technology, life sciences, healthcare and education. The company specializes in designing, fabricating and installing complex HVAC, process piping and other mechanical, electrical and plumbing (MEP) systems for new facilities and upgrading HVAC, lighting and building controls in existing facilities to make them more energy efficient and sustainable.

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

Share on Social Networks: